Shandong Jincheng Pharmaceutical Group Co Ltd
SZSE:300233
Intrinsic Value
Shandong Jincheng Pharmaceutical Group Co., Ltd. engages in the research and development, production and sale of III and IV cephalosporin intermediates and bio-pharmaceuticals. [ Read More ]
The intrinsic value of one Shandong Jincheng Pharmaceutical Group Co Ltd stock under the Base Case scenario is 29.69 CNY. Compared to the current market price of 19.45 CNY, Shandong Jincheng Pharmaceutical Group Co Ltd is Undervalued by 34%.
Valuation Backtest
Shandong Jincheng Pharmaceutical Group Co Ltd
Run backtest to discover the historical profit from buying and selling Shandong Jincheng Pharmaceutical Group Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shandong Jincheng Pharmaceutical Group Co Ltd
| Current Assets | 2.4B |
| Cash & Short-Term Investments | 904m |
| Receivables | 807.4m |
| Other Current Assets | 657.9m |
| Non-Current Assets | 3.5B |
| Long-Term Investments | 147.5m |
| PP&E | 2.5B |
| Intangibles | 842.4m |
| Other Non-Current Assets | 87.5m |
| Current Liabilities | 1.6B |
| Accounts Payable | 558.4m |
| Accrued Liabilities | 214.8m |
| Short-Term Debt | 359.6m |
| Other Current Liabilities | 467.5m |
| Non-Current Liabilities | 601.6m |
| Long-Term Debt | 350.2m |
| Other Non-Current Liabilities | 251.5m |
Earnings Waterfall
Shandong Jincheng Pharmaceutical Group Co Ltd
|
Revenue
|
3.5B
CNY
|
|
Cost of Revenue
|
-2B
CNY
|
|
Gross Profit
|
1.5B
CNY
|
|
Operating Expenses
|
-1.3B
CNY
|
|
Operating Income
|
237.2m
CNY
|
|
Other Expenses
|
-62.5m
CNY
|
|
Net Income
|
174.7m
CNY
|
Free Cash Flow Analysis
Shandong Jincheng Pharmaceutical Group Co Ltd
Profitability Score
Profitability Due Diligence
Shandong Jincheng Pharmaceutical Group Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Shandong Jincheng Pharmaceutical Group Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shandong Jincheng Pharmaceutical Group Co Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Shandong Jincheng Pharmaceutical Group Co Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shandong Jincheng Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Shandong Jincheng Pharmaceutical Group Co Ltd is 5.54 CNY .
Shareholder Return
Price
Shandong Jincheng Pharmaceutical Group Co Ltd
| Average Annual Return | 11.79% |
| Standard Deviation of Annual Returns | 32.56% |
| Max Drawdown | -72% |
| Market Capitalization | 7.5B CNY |
| Shares Outstanding | 380 784 810 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shandong Jincheng Pharmaceutical Group Co., Ltd. engages in the research and development, production and sale of III and IV cephalosporin intermediates and bio-pharmaceuticals. The company is headquartered in Zibo, Shandong and currently employs 3,400 full-time employees. The company went IPO on 2011-06-22. The firm mainly provides active ester side chain of cephalosporin products, other pharmaceutical chemical products, as well as bio-pharmaceuticals and specialty active pharmaceutical ingredient (API). The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Shandong Jincheng Pharmaceutical Group Co Ltd stock under the Base Case scenario is 29.69 CNY.
Compared to the current market price of 19.45 CNY, Shandong Jincheng Pharmaceutical Group Co Ltd is Undervalued by 34%.
You don't have any saved screeners yet
